J. Smolen

593 total citations
9 papers, 378 citations indexed

About

J. Smolen is a scholar working on Rheumatology, Hematology and Infectious Diseases. According to data from OpenAlex, J. Smolen has authored 9 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 3 papers in Hematology and 1 paper in Infectious Diseases. Recurrent topics in J. Smolen's work include Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (3 papers) and Systemic Lupus Erythematosus Research (2 papers). J. Smolen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (3 papers) and Systemic Lupus Erythematosus Research (2 papers). J. Smolen collaborates with scholars based in Austria, Germany and United States. J. Smolen's co-authors include Julia Funovits, D. Aletaha, Daniel L. Baker, Arthur Kavanaugh, Ludwig Erlacher, Gerold Stanek, W. Graninger, Klaus Machold, D. Aletaha and D. van der Heijde and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Value in Health.

In The Last Decade

J. Smolen

9 papers receiving 371 citations

Peers

Countries citing papers authored by J. Smolen

Since Specialization

Citations

This map shows the geographic impact of J. Smolen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Smolen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Smolen more than expected).

Fields of papers citing papers by J. Smolen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Smolen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Smolen. The network helps show where J. Smolen may publish in the future.

Co-authorship network of co-authors of J. Smolen

This figure shows the co-authorship network connecting the top 25 collaborators of J. Smolen. A scholar is included among the top collaborators of J. Smolen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Smolen. J. Smolen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	FRI0133 Understanding Anemia in Rheumatoid Arthritis: The Association of Hemoglobin and Hepcidin Levels with Clinical Disease Activity and Acute Phase Response 2016 ·Annals of the Rheumatic Diseases ·Ivan Padjen, Helga Radner, Leopold Öhler, J. Smolen, Daniel Aletaha	1
2	GOLIMUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION AND FATIGUE IN RA PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF AGENTS: RESULTS FROM THE GO-AFTER STUDY 2010 ·Lara D. Veeken ·(unknown), P Wordsworth, Mittie K. Doyle, J. Smolen, Jacqueline Buchanan, E. L. Matteson, E. C. Hsia, Robert Landewé, (unknown), (unknown), (unknown), (unknown)	3
3	Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis 2010 ·Annals of the Rheumatic Diseases ·(unknown), D. Aletaha, Julia Funovits, Arthur Kavanaugh, Daniel L. Baker, J. Smolen	278
4	Rheumatoide Arthritis 2009 ·Zeitschrift für Rheumatologie ·D. Aletaha, J. Smolen	1
5	Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients 2009 ·Lara D. Veeken ·(unknown), D. Aletaha, Julia Funovits, (unknown), (unknown), J. Smolen	69
6	PMS43 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED RESULTS FROMTHREE PHASE 3 STUDIES 2008 ·Value in Health ·Jacqueline Buchanan, P. Emery, (unknown), J. Smolen, (unknown), E. C. Hsia, (unknown), (unknown), Chengcheng Han, Shreekant Parasuraman	1
7	Infliximab therapy leads to clinical and radiographic benefits in early rheumatoid arthritis patients receiving optimum methotrexate dose 2004 ·Annals of the Rheumatic Diseases ·(unknown), Jean‐Pierre Devogelaer, Kalden, (unknown), Paul Emery, (unknown), D. van der Heijde, Ed Keystone, (unknown), Kalpana Patel, Jung-Yong Han, J. Smolen, (unknown)	4
8	The effect of infliximab therapy on the prevention of new erosions in patients with early rheumatoid arthritis. 2004 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·J. Smolen, D. van der Heijde, Jean‐Pierre Devogelaer, (unknown), M Bala, (unknown), Jung-Yong Han, (unknown)	2
9	REACTIVE ARTHRITIS: UROGENTTAL SWAB CULTURE IS THE ONLY USEFUL DIAGNOSTIC METHOD FOR THE DETECTION OF THE ARTHRITOGENIC INFECTION IN EXTRA-ARTICULARLY ASYMPTOMATIC PATIENTS WITH UNDIFFERENTIATED OLIGOARTHRITIS 1995 ·Lara D. Veeken ·Ludwig Erlacher, (unknown), (unknown), (unknown), Klaus Machold, Gerold Stanek, (unknown), J. Smolen, W. Graninger	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact